Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurines
AssigneeSignal Pharmaceuticals, LLC
InventorsBrydon L. Bennett, Kate Blease, Brian Edwin Cathers
Life of this patent
Estimating the term…
Loading patent…
AssigneeSignal Pharmaceuticals, LLC
InventorsBrydon L. Bennett, Kate Blease, Brian Edwin Cathers
Estimating the term…
Provided herein are Aminopurine Compounds having the following structure: wherein R1, R2 and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.
A method for inhibiting inflammatory cell recruitment or inhibiting inflammatory gene expression, comprising administering to a patient in need thereof an effective amount of a compound having the formula (I):
Dependencies are inferred from the claim text.